Hydralazine Hydrochloride is a highly effective drug use in treatment of severe hypertension and congestive heart failure. It is proven since many years mainly as second line and/or important part of combination treatments.
Hydralazine Hydrochloride has been in Archimica´s portfolio since more than 10 years, with Drug Master Files in the United States and the European Union. Archimica continuously keeps its manufacturing and quality processes to the most modern standards of regulatory and market requirements.
In addition to Hydralazine Hydrochloride Archimica offers Dihydralazine Sulfate, more on Archimica´s webpage soon.
Hydralazine Hydrochloride is manufactured at Archimica´s Lodi, Italy site applying its unique capabilities to use the most challenging reactions, reagents and solvents known in chemistry, under GMP on full industrial scale. In the case of Hydralazine Hydrochloride (and Dihydralazine Sulfate) hydrazine is used as a reactant to build the API molecule. Archimica´s permits and unique industrial infrastructure allow safe, high-quality manufacture complying with highest environmental standards.
Hydralazine Hydrochloride is available form stock in samples and kilogram quantities, and in commercial volumes from 50 to 1000 kgs within 3 months from request.